TARA - Protara Therapeutics names new CFO

• Protara Therapeutics ( NASDAQ: TARA ) appoints Patrick Fabbio as CFO effective January 30, 2023.
• Mr. Fabbio most recently served as President and CFO at NYSE-listed Rafael.
• “We are excited to welcome Pat to the Protara leadership team. With his impressive track record as a financial executive, Pat brings more than 30 years of experience in life science and pharmaceutical companies to Protara. His financial acumen will be essential for the Company as we continue to advance our lead product candidate, TARA-002, for the treatment of non-muscle invasive bladder cancer and lymphatic malformations.” said Jesse Shefferman, CEO.

For further details see: